lenalidomide has been researched along with mevalonic acid in 1 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (mevalonic acid) | Trials (mevalonic acid) | Recent Studies (post-2010) (mevalonic acid) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 3,810 | 33 | 922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloem, AC; Bogers-Boer, L; Lokhorst, HM; van de Donk, NW; van der Spek, E; van Kessel, B | 1 |
1 other study(ies) available for lenalidomide and mevalonic acid
| Article | Year |
|---|---|
Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Humans; Lenalidomide; Mevalonic Acid; Multiple Myeloma; Protein Prenylation; Simvastatin; STAT3 Transcription Factor; Thalidomide | 2009 |